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Background: The present study investigated the effects of a multi-ingredient dietary supplement (MIDS) containing
caffeine, conjugated linoleic acid (CLA), green tea, and branched-chain amino acids (BCAA) taken for 8 weeks on
body composition, blood lipid profile, glucose, insulin, adiponectin, leptin, and high-sensitivity C-reactive protein
(hs-CRP) in overweight and obese men and women.
Methods: Twenty-two participants completed the study (PL, n = 11; 7 women, 4 men; age, 34 ± 3.5 years; height,
169.2 ± 3.3 cm; body mass, 96.9 ± 6.8 kg; BMI, 34.1 ± 1.8 kg/m2; MIDS, n = 11; 9 women, 2 men; age, 36 ± 3.4 years;
height, 173.2 ± 2.9 cm; body mass, 91.9 ± 5.6 kg; BMI, 30.0 ± 1.5 kg/m2). Participants were randomly assigned and
stratified by body fat percentage to two groups: 1) a soybean oil placebo (PL) or 2) MIDS. Each group consumed
two pills with breakfast and two pills with lunch. Body composition and android fat, waist and hip circumferences,
blood pressure and heart rate were measured at baseline and after 8 weeks of supplementation.
Results: There were no significant changes for any of the variables of body composition. Feelings of hunger were
significantly higher in MIDS versus PL with no changes observed in satiety or desire to eat. Heart rate and blood
pressure were unaltered in MIDS after 8 weeks of supplementation. Furthermore, lipid profile, food intake, mood
state variables, fasting blood glucose, and endocrine markers did not significantly change regardless of group.
Conclusion: MIDS intake does not appear to alter body composition or markers of cardiovascular health versus PL.
Moreover, MIDS may actually increase feelings of hunger versus PL.
Keywords: Green tea, Caffeine, Conjugated linoleic acid, Branched chain amino acids, Body composition, ObesityBackground
Obesity is a growing trend in the United States with
current estimates suggesting prevalence as high as 35%
among adults [1]. These high rates potentiate a severe
health crisis as obesity increases the likelihood of develop-
ing chronic diseases which include hypertension, insulin* Correspondence: mormsbee@fsu.edu
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unless otherwise stated.resistance, type 2 diabetes mellitus (T2DM), arterioscler-
osis, coronary heart disease, and metabolic syndrome [2].
Therefore, finding safe and effective methods for reducing
body weight in obese individuals is essential.
Reducing body weight requires manipulation of the en-
ergy balance equation to produce energy deficits. This can
be accomplished through diet and exercise, pharmaco-
logical interventions, or surgical means. However, each of
these methods comes with disadvantages. For instance,
many diet and exercise lifestyle interventions suffer from a
lack of long-term (≥1 yr) adherence [3]. Furthermore,al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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weight are typically expensive and are sometimes accom-
panied by potentially unpleasant and/or dangerous side
effects [4,5]. As such, consideration of alternative weight
loss methods is warranted.
The consumption of natural ingredients and/or dietary
supplements may provide a safe and effective means to
induce weight loss and improve overall health. Indeed,
recent evidence suggests that consumption of certain
multi-ingredient dietary supplements may improve body
composition and mood state [6,7]. The supplements uti-
lized in these studies contained unique proprietary
blends containing such ingredients as caffeine and green
tea extract. These ingredients have been studied exten-
sively and are now recognized as potential modulators of
body weight, composition, adipokines, and metabolic
health [8,9]. Beneficial effects of consuming green tea or
caffeine, respectively, are likely a result of inhibited deg-
radation of catecholamines (epinephrine and norepineph-
rine) or cyclic amino monophospates (cAMP) thereby
enhancing thermogenesis and promoting lipolysis [10,11].
Of interest, the lipolytic effects reported with green tea
and caffeine consumption may be the result of a synergis-
tic effect as noted in a recent meta-analysis [12].
Supplementation with conjugated-linoleic acid (CLA)
and branched-chain amino acids (BCAA) may also provide
weight loss benefits [13,14]. These CLA-derived effects may
be a result of enhanced β-oxidation via stimulation of en-
zymes responsible for transport of lipids into the mitochon-
dria (i.e. carnitine palmitoyl transferase [CPT1]) [15], or
through inhibition of adipocyte differentiation [16]. BCAA
may improve body composition by enhancing protein syn-
thesis, which maintains or increases lean mass [17]. While
the efficacy of these ingredients has been extensively stud-
ied individually, there is a lack of research on the impact of
combining these ingredients on body weight, composition
and other markers of health. Furthermore, combining CLA
and BCAA with green tea extracts and caffeine has also yet
to be studied.
Therefore, the purpose of the present study was to
examine the effects of a multi-ingredient dietary supple-
ment (MIDS) containing a proprietary blend of green tea
extracts, caffeine, CLA, and BCAA on body composition,
blood lipid profile, glucose, insulin, adiponectin, leptin,
and high-sensitivity C-reactive protein (hs-CRP) concen-
trations in overweight and obese men and women.
Methods
Participants
Thirty-four inactive (<2 times/week of planned physical
activity for no more than 60 minutes per session) over-
weight or obese (BMI of 25 to 47 kg/m2) but otherwise
healthy men and women, ages 18–50 years old were re-
cruited from Tallahassee, Florida and surrounding areas.Prior to participation, each participant provided a writ-
ten consent and completed a brief questionnaire regard-
ing his or her medical and exercise training history.
Participants were excluded if they were physically active
(>2 times/week of planned physical activity for > 60 mi-
nutes), if they had uncontrolled hypertension (BP >140/
90 mmHg), if they had high low-density lipoprotein chol-
esterol (LDL >160 mg/dL) or if they took cholesterol
medication. In addition, those diagnosed with cardiovas-
cular disease, stroke, diabetes, thyroid or kidney dysfunc-
tion, and smokers (>5 cigarettes per week) were excluded.
Those who consumed any dietary supplements intended
to alter body composition and body weight were excluded.
In addition, those who had any allergies to soy, wheat, and
grain products that would cause a health problem were ex-
cluded. This study was approved by Florida State University
Institutional Review Board.
Study design
This was a randomized, double-blinded, placebo-controlled
study with two treatment groups. The participants were
stratified based on body fat percentage and assigned to a
placebo group (PL; soybean oil) or an isocaloric multi-
ingredient dietary supplement group (MIDS; Suarez
Corporation Industries, Canton, Ohio; 10 calories; 1 g fat,
99 mg caffeine, 1510 mg of a proprietary blend of: green
tea, CLA, and BCAA per 2-pill serving [2 servings = 4
pills/day]). The green tea was standardized for 45% epi-
gallocatechin gallate and 90% polyphenols. Both groups
ingested 2 identical pills with both breakfast and lunch
7 days per week for 8 weeks.
All laboratory procedures were conducted following an
8 – 10 h overnight fast and a 24 h abstinence from caf-
feine, alcohol intake and any intense physical activity.
Additionally, participants abstained from consuming their
assigned treatment on testing days. Every visit was com-
pleted between 7 am and 10 am.
Anthropometrics
Height and body mass were measured using a wall-mounted
stadiometer and a digital scale (SECA, Birmingham, UK)
every 2 weeks under identical conditions (shorts, t-shirt) for
each subject. Waist and hip circumferences were obtained
at baseline and after 8 weeks using a standard tape meas-
ure (with strain gauge) at the maximum area around the
waist line and around the largest component of the glu-
teus maximus. All circumference measurements were
conducted by the same researcher.
Total and regional body composition was determined by
dual energy X-ray absorptiometry (iDXA; GE Lunar,
Madison, WI) with participants in the supine position.
Total body adiposity was expressed as percent body fat
(% BF). Abdominal adiposity was determined by creat-
ing regions of interest (ROI) for the abdomen (region 1)
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of the iDXA software and included the area just below
the last rib to just above the iliac crest, as described pre-
viously [18]. Abdominal adiposity was expressed as per-
cent android fat (% android fat). A certified radiologist
technician performed all iDXA analyses.
Waist circumferences were measured at the maximum
circumference around the umbilical point. Although this is
not the standard measurement method for waist circumfer-
ence, the abdominal obesity of many of the participants
prevented the use of standard waist measurement tech-
niques (i.e. 1–2 cm below the last rib typically correspond-
ing with the narrowest part of the waist). Measurements
were taken by the same researcher to minimize errors.
Heart rate and blood pressure
Resting heart rate and blood pressure were measured at 0,
2, 4, 6, and 8 weeks. The participants were instructed to
rest in a seated position, with both feet flat on the floor for
5 minutes before measurements were taken. Resting blood
pressures were obtained by the same investigator on the
same arm using an appropriately sized cuff and a sphyg-
momanometer (American Diagnostic Corp., Hauppauge,
NY). Resting heart rate was obtained from a radial pulse.
Two readings were taken for blood pressures and resting
heart rate with 1 min intervals between each reading. The
mean of the two readings were used for statistical analysis.
Questionnaires: dietary intake, physical activity, hunger,
and mood-state
Two-day diet logs were completed at weeks 0, 4, and 8
to quantify calorie and macronutrient intake. The partic-
ipants were asked to maintain their food intake through-
out the duration of the study. The Food Processor
software (version 10.9 ESHA Research Salem, OR, USA)
was used to analyze the food logs.
Participants were asked to not change their physical
activity during intervention period. Physical activity logs
completed by each participant were collected at weeks 0,
4 and 8. Adverse events forms were collected and re-
corded at weeks 2, 4, 6 and 8 by research staff.
Mood state was accessed via the completion of a 65-
question mood state questionnaire which assessed mood
state at weeks 0, 4 and 8. This was a simple likert scale (0,
very – 4, not at all) questionnaire. Hunger was assessed at
the same time points using a simple visual analog scale
(VAS) (1 to 100 mm). Participants were instructed to place
a mark on the 100 mm line to indicate their levels of hun-
ger, satiety, and desire to eat. A mark at 0 indicated a
complete lack of hunger, satiety, or desire to eat and a
mark at 100 indicated extreme hunger, satiety, or desire to
eat for each VAS, respectively. For each of the three mea-
sures (hunger, satiety, and desire to eat), the degree in
which each sensation was felt was quantified by measuringhow far the mark was from the 0 mm mark. For this
measurement, a standard millimeter ruler was used and
all scores were computed by the same investigator. VAS
scales were completed at baseline (week 0) and post-
intervention (week 8) in a fasted state.
Hormones, blood lipids and blood glucose
A venous blood sample (20 ml) was obtained from the ante-
cubital vein at baseline and after 8 weeks of supplementation
(post). Whole blood was used to measure total cholesterol
(TC), high-density lipoprotein cholesterol (HDL-C), low
density lipoprotein cholesterol (LDL-C), triglycerides (TRG),
and glucose concentrations using the Cholestech LDX blood
analysis system (Hayward, CA). Inter-assay coefficients of
variation were 2.1%, 4.0%, 4.1%, 4.7%, and 2.3% for TC,
HDL, LDL, TRG, and glucose, respectively. Remaining
samples were centrifuged (IEC CL3R Multispeed Centrifuge,
ThermoElectron Corporation, Needham Heights, MA) for
15 minutes at 3500 rpm at 4°C. Serum aliquots of 300 μL
were transferred into microtubes and stored at −80°C for
later analysis of insulin, leptin, adiponectin, and hs-CRP.
All assays were performed in duplicate in a single assay
using commercially available ELISA kits according to the
manufacturer’s instructions (leptin and adiponectin: R&D
Systems Inc., Minneapolis, MN, USA; hs-CRP and insulin:
IBL International, Inc., Hamburg, Germany). The mean of
duplicate samples were used for statistical analysis. Inter-
assay coefficients of variation were 1.3%, 6.2%, and 5.2% for
leptin, adiponectin, and hs-CRP, respectively. Inter-assay
data were missing for insulin due to technical errors. Intra-
assay coefficients of variation were 5.6%, 13.8%, 3.8%, and
8.1% for insulin, leptin, adiponectin, and hs-CRP respect-
ively. Insulin resistance was assessed using the homeostatic
model of assessment, as described previously [19].
Compliance
Compliance was checked by asking participants to bring
supplement containers every 4 weeks. Weekly calls or
emails were sent to remind participants to take the sup-
plement and maintain their food and physical activity
logs for the duration of the study.
Statistical analysis
An a priori power analysis was performed which revealed a
need for a minimum of 6 participants per group to achieve a
power of 0.80, α = 0.05, standard deviation = 1.1, difference =
6 (41). One way analysis of variance (ANOVA) was per-
formed to examine possible group differences at baseline.
Data were analyzed using a 2X5 repeated measures ANOVA
([PL × MIDS]) × ([week 0 × week 2 × week 4 × week 6 ×
week 8]). Data were analyzed using JMP PRO 9 software
(Cary, NC). If significant main effects were identified by
ANOVA, a Tukey post hoc comparison test was performed
to locate differences.
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Participant demographics
A total of 160 individuals were pre-screened for participa-
tion in this study. Of the 68 individuals eligible for the
study, 34 decided to participate. Out of these 34 partici-
pants, 5 participants withdrew from the study due to per-
sonal reasons. A total of 29 participants completed the
study, however, data from 7 participants was excluded due
to low compliance (<80% of total supplement intake).
Therefore, 22 participants with 11 in each group were in-
cluded in the statistical analysis. Aside from fat mass
(p<0.05), there were no statistical differences between
groups at baseline (Table 1).
Body composition
Body composition and anthropometric data is presented
in Figure 1 and Table 2. There were no main time or
group × time interactions observed for the following vari-
ables: body mass, body mass index, percent body fat, % an-
droid fat, percent gynoid fat, fat mass, fat free mass,
waist and hip circumference, and waist to hip ratio.
However, a significant time effect was observed for BMI
(+1.2 and +1.0%) and FM (+1.7 and +1.9%) for PL and
MIDS, respectively (Table 2). Additionally, post hoc
analyses revealed no differences between genders.
Lipid profile, heart rate, and blood pressure
The lipid profile variables measured were total cholesterol,
high density lipoprotein, low density lipoprotein and triglyc-
erides. There was no significant main time or group × time
interactions observed for any variables of the lipid profile or
fasting blood glucose (Table 3). We observed a main time
and group × time effect for heart rate. Specifically, heart
rate increased in PL and was unchanged in MIDS (PL, Δ +
4.0 bpm vs. MIDS, Δ 0 bpm, p = 0.005). There was also a
main time and group × time effect for diastolic blood pres-
sure (PL, Δ + 2 mmHg vs. MIDS, Δ -1 mmHg, p = 0.04)
with no changes in systolic blood pressure (Figure 2).Food intake
Dietary intake of total calories, carbohydrates, proteins,
and fats was not different at baseline and did not changeFigure 1 Free-fat mass, fat mass, and percent body fat changes
pre- to post-intervention. A, free fat mass pre- and post-intervention.
B, fat mass pre- and post-intervention. C, body fat percent pre- and
post-intervention. FFM, free-fat mass; kg, kilogram; PL, placebo; MIDS,
multi-ingredient dietary supplement; FM, fat mass; BF, body fat; %,
percent. *denotes that groups were significantly (P < 0.05) different at
week 0 (pre).
Table 1 Participant demographics at week 0 (N = 22)
Variables PL [n = 11
(7 women, 4 men)]
MIDS [n = 11
(9 women, 2 men)]
p
Age (years) 33. 8 ± 3.5 35.9 ± 3.4 0.67
Height (cm) 169.2 ± 3.3 173.2 ± 2.9 0.36
BM (Kg) 96.9 ± 6.8 91.9 ± 5.6 0.57
% BF 43.6 ± 2.5 40.5 ± 2.4 0.45
Data are mean ± SEM. PL, Placebo; MIDS, multi-ingredient dietary supplement;
BM, body mass; BMI, body mass index; %BF, percent body fat; FM, fat mass;
FFM, fat free mass; W/H ratio, wait to hip ratio.
Table 2 Body composition and anthropometrics at week 0 and week 8
Variables Group n Week 0 Week 8 Δ Time p Time × group p
BM (kg) PL 11 96.9 ± 6.8 97.9 ± 7.1 +1.0 0.24 0.70
MIDS 11 91.9 ± 5.6 92.4 ± 5.9 +0.5
BMI (kg/m2) PL 11 34.1 ± 1.8 34.5 ± 1.9 +0.4 0.02 0.62
MIDS 11 30.0 ± 1.5 30.3 ± 1.5 +0.3
% BF PL 11 43.6 ± 2.5 43.8 ± 2.4 +0.2 0.38 0.91
MIDS 11 40.5 ± 2.4 40.7 ± 2.6 +0.2
% Android fat PL 11 49.9 ± 3.2 49.2 ± 2.8 −0.7 0.85 0.07
MIDS 11 44.8 ± 2.8 45.5 ± 3.1 +0.7
% Gynoid fat PL 11 46.5 ± 2.9 46.7 ± 2.7 +0.2 0.63 0.23
MIDS 11 43.0 ± 2.6 42.6 ± 2.8 −0.5
FM (kg) PL 11 41.9 ± 4.8 42.6 ± 4.9 +0.7 0.04 0.84
MIDS 11 36.2 ± 4.0 36.9 ± 4.3 +0.7
FFM (kg) PL 11 54.7 ± 3.2 54.9 ± 3.0 +0.2 0.24 0.50
MIDS 11 54.7 ± 3.3 55.2 ± 3.3 +0.5
Waist (cm) PL 11 107.0 ± 4.3 105.2 ± 3.9 −1.8 0.32 0.69
MIDS 11 99.9 ± 3.2 99.1 ± 3.3 −0.8
Hip (cm) PL 11 121.0 ± 4.9 120.6 ± 4.7 −0.5 0.59 0.90
MIDS 11 114.0 ± 3.3 113.7 ± 3.6 −0.2
Waist to hip ratio PL 11 0.89 ± 0.02 0.88 ± 0.02 −0.01 0.48 0.73
MIDS 11 0.88 ± 0.02 0.87 ± 0.03 −0.01
Data are mean ± SEM; PL, Placebo; MIDS, multi-ingredient dietary supplement; BM, body mass; BMI, body mass index; % BF, percent body fat; % Android fat,
percent Android fat; % Gynoid fat, percent gynoid fat; waist, waist circumference; hip, hip circumference.
Δ change from week 0 to week 8.
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Data are presented in Table 4.
Hunger scale
Ratings of hunger, satiety, and desire to eat are presented
in Figure 3. No significant group × time interactions or
time effects were observed for satiety or desire to eat.
However, a significant group × time interaction wasTable 3 Lipid profile at week 0 and week 8
Variables Group n Week 0
TC (mg/dl) PL 11 179.7 ± 7.9
MIDS 11 178.9 ± 8.6
TRG (mg/dl) PL 10 119.5 ± 18.7
MIDS 11 107.0 ± 19.3
HDL (mg/dl) PL 11 56.1 ± 5.1
MIDS 11 52.4 ± 3.6
LDL (mg/dl) PL 10 102.1 ± 10.7
MIDS 11 105.1 ± 8.6
LDL/HDL PL 10 2.2 ± 0.4
MIDS 11 2.1 ± 0.3
Data are mean ± SEM; PL, Placebo; MIDS, multi-ingredient dietary supplement; TC, t
density lipoprotein; HR, heart rate; SBP, systolic blood pressure; DBP, diastolic blood
Δ change from week 0 to week 8.observed for hunger (PL, Δ - 15.8 mm vs. MIDS, Δ +
10.3 mm, p = 0.04).Mood state
No significant group × time interactions or time effects
were observed for any of the mood state variables. How-
ever, a main time effect (p = 0.02) was observed for tensionWeek 8 Δ Time p Time × group p
183.8 ± 8.8 +4.0 0.39 0.91
184.2 ± 14.2 +5.0
129.7 ± 23.4 +9.0 0.99 0.19
96.9 ± 21.1 −10
50.6 ± 5.1 −5.0 0.39 0.27
53.1 ± 3.9 +1.0
109.3 ± 7.4 +7.0 0.12 0.96
111.8 ± 12.1 +7.0
2.4 ± 0.3 +0.2 0.14 0.68
2.3 ± 0.4 +0.1
otal cholesterol; TRG, triglycerides; HDL, high density lipoprotein; LDL, low
pressure; n is different for TRG, LDL, LDL/HDL as a result of insufficient data.
Figure 2 Systolic and diastolic blood pressure over time.
BP, blood pressure; mmHg, miligrams of mercury; PL, placebo; MIDS,
multi-ingredient dietary supplement. *denotes that PL at week 8 was
significantly (p < 0.05) different than MIDS at weeks 0, 2, 4, and 8.
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vs. MIDS, Δ -1.2).Hormones
Fasting concentrations of insulin, leptin, adiponectin,
and hs-CRP are presented in Table 5. No significant time
effects or group by time interactions were observed for
any of the measured hormones. Additionally, insulin re-
sistance was not different between groups over time andTable 4 Food intake at week 0 and week 8
Variables Group n Week 0
Calories (kcal) PL 10 2666.2 ± 283.1
MIDS 11 2846.0 ± 244.6
Carbohydrate (g) PL 10 335.2 ± 37.1
MIDS 11 333.5 ± 37.3
Carbohydrate (%) PL 10 50.9 ± 2.8
MIDS 11 46.9 ± 3.2
Protein (g) PL 10 93.0 ± 10.6
MIDS 11 112.3 ± 10.0
Protein (%) PL 10 14.8 ± 1.7
MIDS 11 16.8 ± 2.1
Fat (g) PL 10 101.9 ± 14.7
MIDS 11 119.9 ± 15.8
Fat (%) PL 10 33.1 ± 2.1
MIDS 11 37.1 ± 2.5
Data are mean ± SEM; PL, Placebo; MIDS, multi-ingredient dietary supplement.
Δ change from week 0 to week 8.no significant changes were observed in either group
after 8 weeks of treatment.
No significant group by time interactions or time ef-
fects were observed for adiponectin to leptin (A/L) ra-
tio for either group (Table 5). However, A/L ratios
were significantly higher in MIDS at baseline and post-
intervention compared to PL.
Reported side effects
In PL, there was a report of insomnia (n = 1) and bloating
(n = 1). Side effects reported for MIDS were acne (n = 1),
jitteriness (n = 1), nausea (n = 1), weight gain (n = 1), and
loss of appetite (n = 1). No other side effects were reported
in either group.Discussion
The primary findings of this study were that 8 weeks of
MIDS supplementation in overweight/obese men and
women did not reduce body mass or improve body com-
position versus PL. Furthermore, endocrine markers (insu-
lin, leptin, adiponectin, and hs-CRP), blood lipids, satiety,
food intake, and mood state variables were not signifi-
cantly different or after 8 weeks regardless of group.
The results of the present study are in opposition to re-
cent reports of enhanced body composition, mood state,
and mental focus with the consumption of other multi-
ingredient dietary supplements [6,7]. In these studies,
supplements were consumed which contained green tea
extracts and caffeine among other ingredients. As MIDS
shared these ingredients in common with the supplements
used in these studies, the lack of improvement in body
composition was unexpected.Week 8 Δ Time p Time × group p
2366.9 ± 343.1 −299.3 0.36 0.41
2478.5 ± 377.8 −367.5
271.35 ± 39.8 −63.85 0.27 0.63
299.0 ± 55.1 −34.53
46.3 ± 3.3 −4.6 0.31 0.54
47.9 ± 2.5 +1.0
97.2 ± 16.2 +4.2 0.27 0.60
95.4 ± 12.1 −16.9
16.6 ± 1.4 +1.8 0.88 0.55
16.3 ± 1.5 −0.5
91.9 ± 18.0 −10 0.55 0.06
101.6 ± 16.6 −18.3
34.4 ± 3.2 +1.8 0.13 0.08
36.6 ± 2.3 −0.5
Figure 3 Hunger, satiety, and desire to eat ratings pre- and post-intervention. A, hunger ratings pre- and post-intervention. B, satiety
ratings pre- and post-intervention. C, desire to eat ratings pre- and post-intervention. mm, milimeters; PL, placebo; MIDS, multi-ingredient dietary
supplement. *denotes a group × time interaction (p < 0.05).
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either alone or in combination have consistently
reported these ingredients to reduce body mass and fat
mass in overweight or obese individuals [8,20-22]. More-
over, the mechanisms for these effects are also well-
researched. Caffeine stimulates the release of catechol-
amines and inhibits degradation of cAMP, which
enhances sympathetic stimulation [11,23]. Similarly,
green tea can also increase thermogenesis as it contains
caffeine and numerous polyphenols (catechins, epicate-
chin, epigallocatechin, and their gallates). Epigallo
Catechin Gallate (EGCG), the most abundant polyphenol
in GT, prevents catecholamine degradation via inhi-
bition of catechol-o-methlytransferase (COMT) enzyme
activity [10]. This, similar to the effects of caffeine, can
effectively prolong norepinephrine-induced sympathetic
stimulation thereby enhancing thermogenesis [10].Table 5 Endocrine changes at week 0 and week 8
Variables Group n Pre
Insulin (μIU/mL) PL 11 18.8 ± 3.6
MIDS 10 11.4 ± 1.2
Leptin (pg/mL) PL 11 52.2 ± 11.4
MIDS 11 30.7 ± 7.6
Adiponectin (μg/mL) PL 11 5.9 ± 0.8
MIDS 11 9.8 ± 1.7
hs – CRP (mg/L) PL 11 4.4 ± 1.1
MIDS 10 2.8 ± 0.9
Glucose (mg/dl) PL 11 99.0 ± 3.3
MIDS 11 96.3 ± 4.3
HOMA-IR PL 11 4.66 ± 0.98
MIDS 10 2.82 ± 0.44
A/L PL 11 0.36 ± 0.1
MIDS 11 1.1 ± 0.2
Data are mean ± SEM; PL, Placebo; MIDS, multi-ingredient dietary supplement; hs-C
insulin resistance; A, Adiponectin; L, Leptin; n is different for insulin and hs-CRP as d
Δ change from week 0 to week 8.The lack of significant change in body mass or compos-
ition can be explained by a number of factors. Interestingly
the impact of caffeine may be attenuated by the develop-
ment of tolerance. Robertson et al. [24] demonstrated that
caffeine (250 mg/day) increased plasma catecholamines
after 3 days of ingestion in healthy men and women. How-
ever, after 14 days of continuous supplementation the
plasma catecholamine concentrations decreased and were
comparable to the placebo [24]. The participants in our
study were moderate consumers of caffeine (~137 mg/day
as self-reported; range: 0 to ~618 mg/day), possibly result-
ing in attenuated sensitivity to caffeine supplementation
during the trial period. The lack of change in heart rate
and blood pressure in MIDS appears to confirm this. The
ineffectiveness of caffeine in the current study may also be
related to genetic factors. Indeed, Womack et al. [25]
noted a genetic polymorphism which influences one’sPost Δ Time p Time × group p
17.2 ± 1.5 −1.6 0.57 0.16
15.1 ± 2.0 +3.7
42.0 ± 8.1 −10.2 0.13 0.58
25.9 ± 7.5 −4.8
6.5 ± 1.2 +0.6 0.73 0.12
8.9 ± 1.5 −0.9
4.6 ± 1.3 +0.2 0.89 0.37
2.5 ± 0.6 −0.3
98.2 ± 4.4 - 0.8 0.94 0.78
96.9 ± 5.0 +0.6
4.19 ± 0.42 −0.47 0.73 0.19
3.61 ± 0.52 +0.81
0.44 ± 0.1 +0.08 0.13 0.39
1.3 ± 0.23 +0.2
RP, high sensitivity C reactive protein; HOMA-IR, homeostatic model assessment
ata was missing due to technical errors.
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ance. Perhaps the majority of subjects in our study were
‘non-responders’ to caffeine although this is purely specu-
lation. Additionally, a meta-analysis on the body mass and
composition effects of caffeine and GT noted ethnicity
to be a significant factor [26]. Indeed, caffeine and GT
may have more pronounced effects on Asians versus
Caucasians. This may be due to genetic differences in
COMT activity [27]. As our study was composed of vari-
ous ethnicities (e.g. Caucasian, African American, and
Asian), this may have increased variability resulting in the
observed non-significant effects. Finally, the composition
of the multi-ingredient dietary supplements utilized in
other studies [6,7] is significantly different from MIDS.
Thus, the influence of other ingredients may explain the
benefits reported in these studies. Another possibility is
that the ingredients in these other supplements may syn-
ergistically enhance body composition. Alternatively, the
potential benefits of the green tea and caffeine in MIDS
may have been counteracted by some of its other ingredi-
ents, but the experimental design did not allow for exam-
ination of the weighted-effects of the various ingredients.
Our findings of a lack of change in body mass or com-
position is also somewhat unexpected based on reported
benefits of CLA ingestion. CLA, a fatty acid abundant in
seed oils, may aid in the regulation of lipid metabolism.
Specifically, CLA has been reported to reduce uptake of
lipids into adipocytes by inhibiting gene expression and
activity of stearoyl-CoA desaturase and lipoprotein lipase
[28,29]. Additionally, CLA seems to increase the activity
of CPT1 thereby increasing fatty acid oxidation. These
mechanisms may explain improvements in body compos-
ition that have been consistently reported with CLA
supplementation in animals [28,30].
There is some evidence to suggest that CLA improves
body composition in humans. Blankson et al. [31], studied
overweight/obese participants that consumed various
amounts of CLA (1.7, 3.4, 5.1, 6.8 g/day) following exercise
for 12 wks. As a result of the intervention, participants who
received the highest dose of CLA (6.8 g/day) increased lean
mass to a greater degree than the other groups. In addition,
decreases in fat mass were reported in the groups receiving
3.4 and 6.8 g/day CLA, (but not 5.1 g/day). Others have
also reported enhanced lean mass regain following weight
loss in overweight participants with 1.8 to 3.4 g/day of CLA
[32] and reduced % BF in healthy, normal weight, indivi-
duals with 4.2 g/day of CLA [33]. With this in mind, our
findings of no change in body mass or composition could
be the result of sub-optimal doses of CLA. In the current
study, the proprietary blend consumed in MIDS combined
the dose of CLA with BCAA (2.52 g/day composed of CLA
and BCAAs). Thus, even if the majority of the proprietary
blend was composed of CLA, the dose would still likely fall
at the low-end of reported effective dosages (1.8-6.8 g/day).Alternatively, it is also possible that the benefits of CLA are
only realized when combined with exercise [31]. Partici-
pants in our study were inactive prior to and during the
study, which may have influenced the effectiveness of CLA.
Whatever the case may be, our findings are in line with nu-
merous others reporting that CLA supplementation has no
effect on body mass or composition [34-36]. Further study
on the true effects of CLA on body mass and composition
in humans in clearly warranted.
In the present study, body composition was not improved
despite the BCAA content of MIDS. Increasing dietary
protein helps to reduce weight, and preserve lean body
mass in healthy adults [37], and some of the benefits may
be attributable to BCAA [38]. These effects may
be a function of the stimulatory effect that certain BCAA
(e.g. leucine) have on muscle protein synthesis [17]. Positive
effects from BCAA consumption on body composition are
often reported when combined with exercise [39]. However,
the influence of BCAA on body composition in inactive in-
dividuals is relatively unknown. Our findings suggest that
consuming additional BCAA (<2.52 g/day) in combination
with the other ingredients in MIDS has no effect on body
composition. Alternatively, perhaps a higher dose is
required to realize potential benefits. Indeed, many animal
studies reporting BCAA-induced losses in fat mass utilize
>5 g/day [40].
Maintaining low levels of LDL, TC, and TRG and high
levels of HDL may help to prevent cardiovascular disease
[41]. Our findings do not support MIDS as being cardio-
protective as we observed no changes in blood lipids. Some
studies have reported caffeine, green tea, and/or CLA to re-
duce LDL, TC, and TRG while maintaining or increasing
HDL [22,31,42]. However, the doses used in these studies
were typically higher than in the current study and/or were
combined with exercise or dietary interventions. Perhaps
more robust dietary and/or physical activity changes are re-
quired to see significant changes in blood lipids.
Endocrine biomarkers were similarly unaffected by MIDS
or PL. This was not altogether unexpected as the ingredients
in MIDS may have opposing effects on the hormones
measured. For instance, caffeine and CLA are known to re-
duce insulin sensitivity [43,44]. However, caffeine and green
tea have also been reported to increase adiponectin, a hor-
mone produced in adipose that may prevent insulin resist-
ance [45,46]. These opposing effects may explain why insulin
and fasting glucose were unchanged with MIDS. Leptin, a
hormone that may regulate energy intake, and hs-CRP, a
proinflammatory cytokine implicated in atherogenesis, were
similarly unchanged following MIDS supplementation. Al-
though there is some evidence suggesting that CLA may re-
duce leptin levels [47], the effects of the other ingredients on
leptin and hs-CRP are relatively unknown. The results of the
current study suggest that MIDS consumption does not alter
leptin, hs-CRP, or hormones related to insulin sensitivity.
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When attempting to lose weight, increasing satiety may
help to reduce energy intake. Previous studies have re-
ported enhanced satiety with increased dietary protein
intake [37]. Additionally, caffeine supplementation may
reduce spontaneous energy intake [48]. Nevertheless,
we observed no changed in satiety or food intake. As
mentioned, our subjects were moderate caffeine con-
sumers, which likely attenuated any caffeine-mediated
effects on satiety. Moreover, participants in the current
study did not increase dietary protein intake, but rather
supplemented with a relatively small dose of BCAA.
Perhaps BCAAs-alone may have minimal effects on sa-
tiety, or the dose was too small to elicit any changes in
satiety. It is worth noting that participants consuming
MIDS reported an increase in hunger. A study by
Chiou et al. [49] reported that participants taking a
purported dietary supplement, which was actually a
non-caloric placebo, showed a preference for a buffet
meal rather than an organic meal. Furthermore, sub-
jects receiving the sham supplement also showed re-
duced desire to exercise [49]. In the current study, it is
possible that participants that believed they were re-
ceiving a dietary supplement felt increased license for
hedonic behavior possibly contributing to the increased
hunger ratings. However, it should be noted that in the
present study participants in either group did not in-
crease food intake. Thus, further study on the true
effects of MIDS on satiety and hunger are warranted.
In conclusion, consumption of MIDS for 8 wks in over-
weight and obese, but otherwise healthy, men and women
resulted in no changes in body mass or composition,
blood lipids, endocrine biomarkers, mood state, or satiety.
In future studies, larger doses of MIDS should be adminis-
tered, and the effects of MIDS in combination with diet
and/or exercise should be investigated.
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